Papers by Brett P. Monia
Page 2 · newest first
- Factor XI Antisense Oligonucleotide for Prevention of Venous ThrombosisBlood · 2014
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in miceNucleic Acids Research · 2014
- Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic PlaquesArteriosclerosis Thrombosis and Vascular Biology · 2014
- Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular AtrophyCell Reports · 2014
- Thrombin Drives Tumorigenesis in Colitis-Associated Colon CancerCancer Research · 2014
- Mp24-04 Co-Targeting Clusterin and the Androgen Receptor With Ogx-011 and an Ar Antisense Synergistically Enhances Activity of Enzalutamide-Resistant Prostate CancerThe Journal of Urology · 2014
- Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbitsBlood · 2014
- Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung diseaseRare Diseases · 2014
- Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in miceJournal of Clinical Investigation · 2013
- Identification of REST-Regulated Genes and Pathways Using a REST-Targeted Antisense ApproachNucleic Acid Therapeutics · 2013
- Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in AnimalsNucleic Acid Therapeutics · 2013
- Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese MicePLoS ONE · 2013
- Preclinical Evaluation of the Toxicological Effects of a Novel Constrained Ethyl Modified Antisense Compound Targeting Signal Transducer and Activator of Transcription 3 in Mice and Cynomolgus MonkeysNucleic Acid Therapeutics · 2013
- Inhibition of Vascular Permeability by Antisense-Mediated Inhibition of Plasma Kallikrein and Coagulation Factor 12Nucleic Acid Therapeutics · 2013
- Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in PrimatesArteriosclerosis Thrombosis and Vascular Biology · 2013
- Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in miceJournal of Clinical Investigation · 2013
- Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathyAmyloid · 2012
- The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2Journal of Lipid Research · 2012
- Genomic Analysis of wig-1 PathwaysPLoS ONE · 2012
- Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeysBlood · 2012
- Inhibition of hepatic sulfatase-2 In Vivo : A novel strategy to correct diabetic dyslipidemiaHepatology · 2012
- ISIS-FXIRx, A Novel and Specific Antisense Inhibitor of Factor XI, Caused Significant Reduction in FXI Antigen and Activity and Increased aPTT without Causing Bleeding in Healthy VolunteersBlood · 2011
- Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosisAmyloid · 2011
- Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleedingBlood · 2011
- Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domainBlood · 2011
- Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivoMolecular Cancer Therapeutics · 2011
- Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding riskBlood · 2010
- Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatmentAmyloid · 2010
- Peptide Nucleic Acids Conjugated to Short Basic Peptides Show Improved Pharmacokinetics and Antisense Activity in Adipose TissueJournal of Medicinal Chemistry · 2010
- Antisense oligonucleotide targeting of insulin‐like growth factor‐1 receptor (IGF‐1R) in prostate cancerThe Prostate · 2009
- SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic ratsProceedings of the National Academy of Sciences · 2009
- Inhibition of Protein Tyrosine Phosphatase-1B with Antisense Oligonucleotides Improves Insulin Sensitivity and Increases Adiponectin Concentrations in MonkeysEndocrinology · 2009
- Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Cα activates binding of the C subunit of protein kinase A to the 3′-untranslated region of the lipoprotein lipase mRNABiochemical Journal · 2008
- Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese miceAJP Endocrinology and Metabolism · 2008
- Comparing In Vitro and In Vivo Activity of 2′-O-[2-(Methylamino)-2-oxoethyl]- and 2′-O-Methoxyethyl-Modified Antisense OligonucleotidesJournal of Medicinal Chemistry · 2008
- Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expressionAJP Endocrinology and Metabolism · 2008
- Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitisHepatology · 2007
- Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin ResistanceJournal of Biological Chemistry · 2007
- Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitisHepatology · 2007
- Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma CellsCancer Research · 2007
- Reduction of Low Molecular Weight Protein-tyrosine Phosphatase Expression Improves Hyperglycemia and Insulin Sensitivity in Obese MiceJournal of Biological Chemistry · 2007
- Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseJournal of Clinical Investigation · 2007
- Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic miceJournal of Lipid Research · 2007
- Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animalsNucleic Acids Research · 2006
- Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 DiabetesEndocrinology · 2006
- Anti-Inflammatory Activity of Inhaled IL-4 Receptor-α Antisense Oligonucleotide in MiceAmerican Journal of Respiratory Cell and Molecular Biology · 2006
- Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin ActionDiabetes · 2006
- Loss of PTEN is associated with progression to androgen independenceThe Prostate · 2006
- Comparison of strategies targeting Raf-1 mRNA in ovarian cancerInternational Journal of Cancer · 2005
- Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell linesMelanoma Research · 2005